PUTNAM INVESTMENTS LLC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 219 filers reported holding NPS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$2,360,000
+36.8%
65,976
-0.6%
0.01%
+25.0%
Q3 2014$1,725,000
-20.0%
66,341
+1.7%
0.00%
-20.0%
Q2 2014$2,157,000
+10.6%
65,259
+0.2%
0.01%
+25.0%
Q1 2014$1,950,000
-16.2%
65,146
-15.0%
0.00%
-33.3%
Q4 2013$2,328,000
+45.5%
76,677
+52.4%
0.01%
+50.0%
Q3 2013$1,600,00050,3070.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders